Caricamento...
Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
OBJECTIVE: To estimate the risk of progressive multifocal leukoencephalopathy (PML) and the safety of natalizumab administration in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: A descriptive retrospective observational study including all patients with RRMS treated with nata...
Salvato in:
| Pubblicato in: | Eur J Hosp Pharm |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7907687/ https://ncbi.nlm.nih.gov/pubmed/33608441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2019-002048 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|